User profiles for Stephen A Lauer
 | Stephen A LauerCertilytics, Inc Verified email at certilytics.com Cited by 11756 |
The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application
Background: A novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
was identified in China in December 2019. There is limited support for many …
was identified in China in December 2019. There is limited support for many …
Two copies of the human apolipoprotein CI gene are linked closely to the apolipoprotein E gene.
SJ Lauer, D Walker, NA Elshourbagy… - Journal of Biological …, 1988 - Elsevier
The gene for human apolipoprotein (apo) CI was selected from human genomic cosmid and
lambda libraries. Restriction endonuclease analysis showed that the gene for apoC-I is …
lambda libraries. Restriction endonuclease analysis showed that the gene for apoC-I is …
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
Background Assessing the burden of COVID-19 on the basis of medically attended case
numbers is suboptimal given its reliance on testing strategy, changing case definitions, and …
numbers is suboptimal given its reliance on testing strategy, changing case definitions, and …
[HTML][HTML] Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
J Perez-Saez, SA Lauer, L Kaiser, S Regard… - The Lancet Infectious …, 2021 - thelancet.com
The infection fatality risk (IFR) is the average number of deaths per infection by a pathogen
and is key to characterising the severity of infection across the population and for specific …
and is key to characterising the severity of infection across the population and for specific …
Variation in false-negative rate of reverse transcriptase polymerase chain reaction–based SARS-CoV-2 tests by time since exposure
Background: Tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based
on reverse transcriptase polymerase chain reaction (RT-PCR) are being used to rule out …
on reverse transcriptase polymerase chain reaction (RT-PCR) are being used to rule out …
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
…, C Atyeo, AJ Iafrate, SB Calderwood, SA Lauer… - Science …, 2020 - science.org
We measured plasma and/or serum antibody responses to the receptor-binding domain (RBD)
of the spike (S) protein of SARS-CoV-2 in 343 North American patients infected with …
of the spike (S) protein of SARS-CoV-2 in 343 North American patients infected with …
[PDF][PDF] Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group …
…, B Cushing, R Giller, L Cohen, SJ Lauer… - Journal of clinical …, 1999 - researchgate.net
Purpose: To determine whether the 3-year eventfree survival (EFS) of children with completely
resected immature teratomas is greater than 85%. Patients and Methods: Patients with …
resected immature teratomas is greater than 85%. Patients and Methods: Patients with …
Prospective forecasts of annual dengue hemorrhagic fever incidence in Thailand, 2010–2014
Dengue hemorrhagic fever (DHF), a severe manifestation of dengue viral infection that can
cause severe bleeding, organ impairment, and even death, affects between 15,000 and …
cause severe bleeding, organ impairment, and even death, affects between 15,000 and …
Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple …
…, JJ Shuster, R Nitschke, SJ Lauer… - Journal of Clinical …, 1998 - ascopubs.org
PURPOSE To describe the incidence of acute neurotoxicity (NT) in children with lower risk B-precursor
acute lymphoid leukemia (ALL) treated with intermediate-dose methotrexate (MTX…
acute lymphoid leukemia (ALL) treated with intermediate-dose methotrexate (MTX…
[PDF][PDF] Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents …
…, R Giller, JW Cullen, NM Marina, SJ Lauer… - Journal of Clinical …, 2004 - researchgate.net
Purpose To determine in a randomized comparison whether combination chemotherapy
with high-dose cisplatin (HDPEB) improves the event-free (EFS) and overall (OS) survival of …
with high-dose cisplatin (HDPEB) improves the event-free (EFS) and overall (OS) survival of …
